Goldman Sachs’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-208,028
| Closed | -$5.63M | – | 5055 |
|
|
2024
Q2 | $5.63M | Sell |
208,028
-651,153
| -76% | -$17.6M | ﹤0.01% | 2527 |
|
|
2024
Q1 | $15.7M | Sell |
859,181
-1,151,802
| -57% | -$21.1M | ﹤0.01% | 1704 |
|
|
2023
Q4 | $24.7M | Buy |
2,010,983
+1,762,048
| +708% | +$21.6M | ﹤0.01% | 1418 |
|
|
2023
Q3 | $3.73M | Buy |
248,935
+144,939
| +139% | +$2.17M | ﹤0.01% | 2685 |
|
|
2023
Q2 | $3.38M | Sell |
103,996
-8,210
| -7% | -$267K | ﹤0.01% | 2841 |
|
|
2023
Q1 | $4.39M | Sell |
112,206
-36,083
| -24% | -$1.41M | ﹤0.01% | 2643 |
|
|
2022
Q4 | $7.84M | Buy |
148,289
+19,858
| +15% | +$1.05M | ﹤0.01% | 2306 |
|
|
2022
Q3 | $5.78M | Buy |
128,431
+55,789
| +77% | +$2.51M | ﹤0.01% | 2537 |
|
|
2022
Q2 | $2.64M | Buy |
72,642
+15,928
| +28% | +$580K | ﹤0.01% | 3225 |
|
|
2022
Q1 | $2.34M | Sell |
56,714
-35,443
| -38% | -$1.46M | ﹤0.01% | 3462 |
|
|
2021
Q4 | $3.93M | Buy |
92,157
+38,987
| +73% | +$1.66M | ﹤0.01% | 2992 |
|
|
2021
Q3 | $2.93M | Sell |
53,170
-1,996
| -4% | -$110K | ﹤0.01% | 3193 |
|
|
2021
Q2 | $2.64M | Sell |
55,166
-16,297
| -23% | -$780K | ﹤0.01% | 3290 |
|
|
2021
Q1 | $3.62M | Buy |
71,463
+19,352
| +37% | +$980K | ﹤0.01% | 2912 |
|
|
2020
Q4 | $3.28M | Sell |
52,111
-34,216
| -40% | -$2.15M | ﹤0.01% | 2753 |
|
|
2020
Q3 | $5.8M | Sell |
86,327
-140,943
| -62% | -$9.47M | ﹤0.01% | 2292 |
|
|
2020
Q2 | $9.52M | Buy |
227,270
+42,623
| +23% | +$1.79M | ﹤0.01% | 1976 |
|
|
2020
Q1 | $5.81M | Sell |
184,647
-22,998
| -11% | -$724K | ﹤0.01% | 2150 |
|
|
2019
Q4 | $8.39M | Buy |
207,645
+44,036
| +27% | +$1.78M | ﹤0.01% | 2132 |
|
|
2019
Q3 | $5.32M | Buy |
163,609
+5,267
| +3% | +$171K | ﹤0.01% | 2285 |
|
|
2019
Q2 | $7.67M | Buy |
+158,342
| New | +$7.67M | ﹤0.01% | 2090 |
|